Safe and Healthy Beginnings. M. Jeffrey Maisels MD William Beaumont Hospital Royal Oak, MI

Similar documents
Background OVER 30 ISSUES IDENTIFIED! Key opportunities. What we ve done. October 31, 2012

11/8/12. KERNICTERUS: The reason we have to care about bilirubin. MANAGING JAUNDICE IN THE BREASTFEEDING INFANT AKA: Lack of Breastfeeding Jaundice

Crash Cart therapy for Severe Jaundice. Dr Sandeep Kadam Neonatologist Pune

Revised Authors: Malathi Balasundaram MD, Vinod K. Bhutani, MD, FAAP

Approach to the management of Hyperbilirubinemia in Term Newborn Infant

Breastfeeding, Jaundice and Hyperbilirubinemia in the Newborn. Jeremy Jones, DO Oklahoma State University Center for Health Sciences

Severe neonatal hyperbilirubinemia leading to exchange transfusion

T. Jarumanee, M. Dokkaew, S. Pimnamyen, I. Rattarasarn Advisors: C. Boonsopha, MD., S. Leartkajonsin, MD.

Table 1. Agents to be avoided in G6PD Deficiency Patients MANAGEMENT OF NNJ

Acute Bilirubin Encephalopathy in Healthy Term Neonates Requiring Exchange Transfusion

Determination of effect of low dose vs moderate dose clofibrate on decreasing serum bilirubin in healthy term neonates

Clinical evaluation Jaundice skin and mucous membranes

Risk Factors ff Jaundice in Neonates at DHQ Teaching Hospital Dera Ghazi Khan

Recent Advances in Understanding Neonatal Hemolytic Disease

PAEDIATRIC ACUTE CARE GUIDELINE. Jaundice Neonatal

Cord blood bilirubin used as an early predictor of hyperbilirubinemia

Management of Indirect Neonatal Hyperbilirubinemia

What to Do when the Lights Don t Work- Neonatal Hyperbilirubinemia

Comparison of Two Phototherapy Methods (Prophylactic vs Therapeutic) for Management of Hyperbilirubinemia in Very Low Birth Weight Newborns

COMPARISON OF TWO TRANSCUTANEOUS BILIRUBINOMETERS - MINOLTA AIRSHIELDS JAUNDICE METER JM103 AND SPECTRX BILICHECK - IN THAI NEONATES

Cord blood albumin as a predictor of neonatal hyperbilirubinemia in healthy neonates.

Jaundice in newborn babies under 28 days

Newborn infants require early follow-up and appropriate treatment of hyperbilirubinemia to avoid adverse outcomes such

Neonatal Jaundice Hyperbilirubinemia

Department of Pediatrics, Coimbatore Medical College Hospital, Coimbatore, Tamilnadu, India Correspondence to: Senthilkumar P,

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Neonatal Jaundice for Infants 35 Weeks Gestational Age v.3

Low temperature < 96.8 F (36.0 C) rectally that doesn't respond to warming

Predicting Significant Hyperbilirubinaemia and Early Discharge for Glucose-6-Phosphate Dehydrogenase Deficient Newborns

Yellow baby. Subtitle

The American Academy of Pediatrics (AAP) requested

Outcome of Neonatal Hyperbilirubinemia in a Tertiary Care Hospital in Bangladesh

Original Article Effect of Intravenous Fluid Supplementation on Serum Bilirubin Level in Jaundiced Healthy Neonates during Conventional Phototherapy

Comparing Transcutaneous to Serum Bilirubin after Phototherapy in the Outpatient Setting

A STUDY OF REBOUND HYPERBILIRUBINEMIA IN POST PHOTOTHERAPY NEONATES

Neonatal Jaundice HOPE. Doa'a Al Zou'bi & Nadeen Al-share'

Evaluation of the BiliChek Noninvasive Bilirubin Analyzer for Prediction of Serum Bilirubin and Risk of Hyperbilirubinemia

CORD BLOOD TESTING AND HDFN A CASE STUDY. Eric Rosa, MLS (ASCP) CM University of Kansas Hospital April 20, 2016

WHAT IT MEANS or WHY YOU DO IT

Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants. Section Editor Steven A Abrams, MD

Neurodevelopmental Risk?

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

CLINICAL PRACTICE GUIDELINE

Evaluation of the first day transcutaneous bilirubin (TcB) level as a predictor of hyperbilirubinemia in healthy term neonates

I n the past 15 years, severe hyperbilirubinaemia has been

The online version of this article, along with updated information and services, is located on the World Wide Web at:

EFFICACY OF CLOFIBRATE ON SEVERE NEONATAL JAUNDICE ASSOCIATED WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY (A RANDOMIZED CLINICAL TRIAL)

Applying data mining techniques to improve diagnosis in neonatal jaundice

infant s gestational age, age at phototherapy initiation, and TSB relative to the treatment threshold at phototherapy termination.

ARTICLE. Jaundice Noted in the First 24 Hours After Birth in a Managed Care Organization

JMSCR Vol 05 Issue 04 Page April 2017

Under-five and infant mortality constitutes. Validation of IMNCI Algorithm for Young Infants (0-2 months) in India

A Prospective Comparison of Transcutaneous and Serum Bilirubin Within Brief Time Intervals

Fluid supplementation in term neonates with severe hyperbilirubinemia: a randomized controlled trial study

Developing clinical decision support for management of neonatal hyperbilirubinemia

Implementation of a transcutaneous bilirubinometer in a newborn nursery A randomized controlled trial

An Approach to Jaundice Block 10. Dr AJ Terblanche Department of Paediatrics and Child Health

An Evidence-Based View on Hyperbilirubinemia: Nice to know or Must-know?

PRACTICE GUIDELINES WOMEN S HEALTH PROGRAM

Transcutaneous bilirubin measurements in the assessment and management of neonatal jaundice

Effect of intravenous fluid supplementation on serum bilirubin level during conventional phototherapy of term infants with severe hyperbilirubinemia

BIBLIOGRAPHY Newborn Jaundice Management

Vijay L. Grey McMaster University

Hyperbilirubinemia occurs in most healthy newborn

Neonatal jaundice. Vad menar folk när de Say Någon kan inte se skogen för alla träd?

for jaundice, each will miss some infants with a TSB level at/above the phototherapy threshold.

Clinical Policy Title: Home phototherapy for hyperbilirubinemia

Tests and treatment for your baby s jaundice

Randomized Controlled Trial of Compact Fluorescent Lamp Versus Standard Phototherapy for the Treatment of Neonatal Hyperbilirubinemia

OB Well Baby Nursery Admission (Term) [ ] For specialty focused order sets for your patient, refer to: General

Summary of Changes: References/content updated to reflect most current standards of practice.

The joint use of human and electronic eye: visual assessment of jaundice and transcutaneous bilirubinometry

Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings

Umbilical cord blood acid-base analysis and the development of significant hyperbilirubinemia in near-term and term newborns: a cohort study

Prognostic value of peripheral blood eosinophil count on first day of infancy in the incidence of neonatal hyperbilirubinemia

Jaundice Management: Research Study Tool

hyperbilirubinemia in very low birth weight

Evaluation of a point-of-care direct spectrophotometric method for measurement of total serum bilirubin in term and near-term neonates

REVIEW ARTICLE. Transcutaneous Bilirubin Nomograms. A Systematic Review of Population Differences and Analysis of Bilirubin Kinetics

Clinical Policy Title: Home phototherapy for hyperbilirubinemia

- Author's note: IAQ's are intended for training purposes and not meant to be required on every call.

Research Questions: Methods:

Etiological profile of neonatal hyperbilirubinaemia in the rural area of Rajasthan

Pankaj Kumar Jain*, Surendra Meena, Kailash Meena

W1A- Cases I Learned From

Determining the Correlation and Accuracy of Three Methods of Measuring Neonatal Bilirubin Concentration

Evening Case studies, Tuesday April 30, Vijay L. Grey McMaster University

Prolonged Neonatal Jaundice

PHOTOTHERAPY; COMPARISON OF NEW IMPROVISED VERSUS CONVENTIONAL METHODS AMONG NEONATES WITH JAUNDICE

Influence of skin colour on diagnostic accuracy of the jaundice meter JM 103 in newborns

Phototherapy and Seizures: Should We Change Practice?

Seyed Hossein Saadat¹, Salma Naderi¹, Shahram Zare², Samira Khalili³, Behnaz Darban 4, Rakhshaneh Goodarzi¹*

Kernicterus: A Preventable Neonatal Brain Injury

A Study of Prevalence and Risk Factors of Polycythemia in Neonatal Nursery in Duhok

Morbidity and Mortality Among Exclusively Breastfed Neonates With MCAD Deficiency

Prediction of Severe Neonatal Hyperbilirubinemia Using Cord Blood Hydrogen Peroxide: A Prospective Study

Transcutaneous bilirubin estimation in extremely low birth weight infants receiving phototherapy: a prospective observational study

Management. (By the World Health Organization according to the magnitude of the enzyme deficiency and the severity of hemolysis)

Prior Authorization Review Panel MCO Policy Submission

Transcription:

Safe and Healthy Beginnings M. Jeffrey Maisels MD William Beaumont Hospital Royal Oak, MI jmaisels@beaumont.edu

Risk Factors There are 2 kinds Those that increase the risk of subsequently developing a high bilirubin level ( gestation, breastfeeding, TSB/TcB >75 tth percentile, bruising etc). Use these in assessing risk before the baby is discharged and at the first follow up visit Those that increase the risk of brain damage at a particular bilirubin level. Use these in deciding when to start phototherapy or do an exchange transfusion

Risk Factors for Developing Hyperbilirubinemia TSB or TCB >75% Jaundice <24hr or before discharge ABO with +ve DAT or other hemolytic disease (G6PD) Gestation <39wk Previous sibling jaundiced Cephalhematoma or bruising (vacuum) Exclusive breastfeeding East Asian Male Discharge <72hr

Risk Factors for Brain Damage in Infant with Hyperbilirubinemia Isoimmune hemolytic disease G6PD deficiency Asphyxia Significant lethargy Temperature instability Sepsis Acidosis

RISK OF BEING READMITTED FOR PHOTOTHERAPY 30,000 discharges from well baby nursery 1988-94 4.2/1,000 readmitted for phototherapy RISK FACTOR 36 wks 36 38 wks Breast feeding Jaundice in nursery LOS < 72 h ODDS RATIO 13.2 7.5 4.2 7.8 3.2 Maisels MJ, Pediatrics 1998;101:995

Newman, Arch Ped Adolesc Med 2005;159:113

Predischarge Risk Assessment Combining predischarge TSB or TcB with risk factors provides most accurate prediction Cannot rely on TSB or TcB alone because false negatives occur Still need to look at the baby and consider risk factors

Follow-up Discharge <72hr, see within 2 days Can adjust this according to time of discharge and risk factors If cannot see in 2 days, assess risk, do TcB or TSB and make alternative plan - home nurse visit - see in after hours clinic - outpatient TSB or TcB

Phototherapy Guidelines for Infants >35 wks Gestation Total Serum Bilirubin (mg/dl0 25 20 15 10 5 0 Infants at lower risk = > 38 wk. and well Infants at medium risk= > 38 wk. +risk factors or 35 37 6/7 wk. & well Infants at higher risk= 35-37 6/7 wk. + risk factors Birth 24 h 48 h 72 h 96 h 5 Days 6 Days 7 Days Age Guidelines refer to use of intensive phototherapy. Use total bilirubin. Do not subtract direct reacting or conjugated bilirubin Risk factors*= isoimmune hemolytic disease, G6PD deficiency, asphyxia, respiratory distress, significant lethargy, temperature instability, sepsis, acidosis, or albumin < 3.0 g/dl (if measured) For well infants 35-36 6/7 wk can adjust TSB levels for intervention around the medium risk line. It is an option to intervene at lower TSB levels for infants closer to 35 wks and at higher TSB levels for those closer to 37 6/7 wks. It is an option to provide conventional phototherapy in hospital or at home at TSB levels 2-3 mg/dl below those shown but home phototherapy should not be used in any infant with risk factors. *The risk factors listed above are conditions that might affect the likelihood of brain damage at different bilirubin levels. These factors increase the risk of brain damage because of their negative effects on albumin binding of bilirubin, the integrity of the blood brain barrier, and the susceptibility of the brain cells to damage by bilirubin. Guidelines for Exchange Transfusion in infants > 35 wk Gestation Total Serum Bilirubin (mg/dl) 30 25 20 15 Infants at lower risk = > 38 wk. and well Infants at medium risk= > 38 wk. +risk factors or 35 37 6/7 wk. & well Infants at higher risk= 35-37 6/7 wk. + risk factors 10 Birth 24 h 48 h 72 h 96 h 5 Days 6 Days 7 Days Age The dashed lines for the first 24 hours indicate uncertainty due to a wide range of clinical circumstances and a range of responses to phototherapy Perform immediate exchange if infant shows signs of acute bilirubin encephalopathy, ( hypertonia, arching, retrocollis, opisthotonos, fever, high pitched cry)or if TSB is >5 mg/dl above these lines. Risk factors = isoimmune hemolytic disease, G6PD deficiency, asphyxia, respiratory distress, significant lethargy, temperature instability, sepsis, acidosis. Measure serum albumin and evaluate B/A ratio = bilirubin ( mg/dl) / albumin (g/dl). See the table below. Use total bilirubin. Do not subtract direct reacting or conjugated bilirubin If TSB above exchange transfusion line, repeat every 2-3 hrs until TSB decreases for 2 consecutive measurements. In isoimmune hemolytic disease give IVIG 0.5 1g/kg over 2-3 hours if TSB is rising and within 2-3 mg/dl of exchange level. This can be repeated in 12 hr. If infant is well and 35-36 6/7 wk (medium risk) can individualize TSB levels for exchange based on actual gestational age The risk factors listed above are conditions that might affect the likelihood of brain damage at different bilirubin levels. These factors increase the risk of brain damage because of their negative effects on albumin binding of bilirubin, the integrity of the blood brain barrier, and the susceptibility of the brain cells to damage by bilirubin During birth hospitalization, exchange transfusion is recommended if the TSB rises to these levels despite intensive phototherapy. For readmitted infants, if the TSB level is above the exchange level, repeat TSB measurement every 2 to 3 hours and consider exchange, if the TSB remains above the levels indicated after intensive phototherapy for 6 hours. The following B/A ratios can be used together with but not in lieu of the TSB level as an additional factor in determining the need for exchange transfusion. B/A Ratio at Which exchange Transfusion Risk Category Should be considered TSB mg/dl Lower Risk 8.0 Medium Risk 7.2 Higher Risk 6.8 If the TSB is at or approaching the exchange level, send blood for immediate type and cross match. Blood for exchange transfusion is modified whole blood. (red cells and plasma) cross matched against the mother and compatible with the infant.

Predischarge TcB Percentiles and Subsequent Hyperbilirubinemia Post Discharge Total Serum Bilirubin Relative Risk vs < 50 th Percentile (95% CI) TcB Percentil es Total Populatio n 17 mg/dl (75) 20 mg/dl (21) 17 mg/dl 20 mg/dl n % n % < 50 5727 3 0.05 0 --- 50-75 2864 21 0.73 8 0.27 14.0 (4.2, 46.9) 76-95 2291 24 1.04 7 0.31 20.0 (6, 66.3) > 95 574 27 4.70 6 1.05 89.8 (27.3, 295) Totals 11456 75 0.65 21 0.18 16 (2.0, 128) 17.5 (2.2, 142) 59.9 (7.2, 496) * Relative risk calculated assuming a value of 1 for post discharge TSB of 20 mg/dl with predischarge TcB below 50 th percentile

Physiologic Mechanisms of Neonatal Jaundice Increased load including enterohepatic circulation Decreased hepatic uptake Decreased conjugation But which of these is most important?

Well baby nursery, infants 36 weeks Routine TcB (JM-102) by nurses if infant jaundiced TSB by protocol according to TcB If TSB > 75 th percentile (Bhutani) = study group (n=108) Controls no jaundice (no TcB) or TSB < 75 th percentile (n=164) ETCOc

Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for Subsequent Significant Hyperbilirubinemia in Healthy Term and Near-Term Newborns Bhutani VK, Johnson L, Sivieri EM. Pediatrics 1999;103:6-14

ETCOc in Jaundiced and Control Infants 4 3.5 Jaundice Control 3 ETCOc (ppm) 2.5 2 1.5 1 0.5 0 20 60 70 59 11 34 7 11 Day 1 Day 2 Day 3 Day 4-5 Age Maisels. Pediatrics 2006;118: 276-279

Conclusion Increased heme catabolism (and bilirubin production) are probably the primary events responsible for jaundice in the first 4 days Newborns have decreased ability to conjugate but if there was no increase in production would see far less jaundice Drugs that interfere with bilirubin production could eliminate most neonatal jaundice

Kernicterus Registry 125 cases in USA of infants born between 1979-2002 and discharged as healthy newborns Sources - parents, physicians, nurses, literature, medico-legal 69% male Nearly all breastfed 97% discharged <72 hr (57.5% <48hr) 40% <38 weeks Bhutani et al, J Perinatol 2004;24:650